(Q47671261)

English

Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction).

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

Jerry H Gurwitz

3

object named as

Gurwitz JH

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

author name string

Goldberg RJ

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Mooradd M

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Rogers WJ

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

French WJ

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Barron HV

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Gore JM

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

language of work or name

0 references

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

82

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

259-264

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

The open-artery theory is alive and well--again

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Incidence and case fatality rates of acute myocardial infarction (1975–1984): The Worcester Heart Attack Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Delay between onset of chest pain and seeking medical care: the effect of public education

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Causes of delay in seeking treatment for heart attack symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Implications for acute intervention related to time of hospital arrival in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

The prehospital phase of acute myocardial infarction in the era of thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900342-7

7 January 2021

Identifiers

10.1016/S0002-9149(98)00342-7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/9708650

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47671261&oldid=1527445191"